Key result
Reduced PetCO2 at the ventilatory threshold (<36 mm Hg) in heart failure patients was associated with lower peak cardiac output during exercise compared to normal PetCO2 and healthy controls (P=0.04).
Why the study?
Does end-tidal CO2 pressure at the ventilatory threshold correlate with cardiac performance during exercise in patients with heart failure?
Cross-Sectional (n=61)
Does end-tidal CO2 pressure at the ventilatory threshold correlate with cardiac performance during exercise in patients with heart failure?
Absolute Event Rate: 13.7% vs 17.8%
p-value: p=0.04
Reduced end-tidal CO2 pressure at the ventilatory threshold reflects impairments in functional, ventilatory, and cardiac performance during exercise in heart failure patients.
PetCO2@VT may supplement CPX for HF functional assessment; leaves open whether it adds incremental prognostic value.
INTRODUCTION: In patients with heart failure (HF), end-tidal CO2 pressure (PetCO2) is related to ventricular function at rest and has been shown to predict prognosis. However, little is known about the association between ventricular performance and PetCO2 responses to exercise. METHODS: Forty-eight patients with HF and 13 normal subjects underwent cardiopulmonary exercise testing (CPX), while cardiac output and other hemodynamic measurements at rest and during exercise were obtained using a novel, noninvasive, bioreactance device based on assessment of relative phase shifts of electric currents injected across the thorax, heart rate, and ventricular ejection time. CPX responses and indices of cardiac performance were compared between normal subjects and HF patients achieving above and below a PetCO2 of 36 mm Hg at the ventilatory threshold (PetCO2@VT). RESULTS: HF patients with an abnormal PetCO2@VT (<36 mm Hg) had a lower exercise capacity, a lower .VO2@VT, a higher .V_E/.VCO2 slope, and lower oxygen uptake efficiency slope (OUES) values compared with normal subjects and patients achieving a normal PetCO2@VT. Patients with reduced PetCO2@VT had lower peak cardiac output responses to exercise (20.0 +/- 10, 17.8 +/- 6, and 13.7 +/- 7 L x min for normal subjects and HF patients with normal and abnormal PetCO2 responses to exercise, respectively, P = 0.04). PetCO2@VT was inversely related to the .V_E/.VCO2 slope (r = -0.78, P < 0.001) and directly related to the OUES (r = 0.55, P < 0.001). CONCLUSION: Reduced PetCO2 reflects impairments in the functional, ventilatory, and cardiac performance response to exercise in patients with HF. PetCO2 can supplement other clinical and CPX indices in the functional and prognostic evaluation of patients with HF.
No takes yet. Share an insight, caveat, or question.
Myers et al. (2008) conducted a cross-sectional in Heart failure (n=61). Abnormal PetCO2 at ventilatory threshold (<36 mm Hg) vs. Normal subjects and HF patients with normal PetCO2@VT was evaluated on Peak cardiac output response to exercise (p=0.04). Reduced PetCO2 at the ventilatory threshold (<36 mm Hg) in heart failure patients was associated with lower peak cardiac output during exercise compared to normal PetCO2 and healthy controls (P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: